½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1556169

¼¼°èÀÇ 3D ½ÉÀå ¸ÅÇÎ ½Ã½ºÅÛ ½ÃÀå º¸°í¼­(2024³â)

3D Cardiac Mapping System Global Market Report 2024

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Business Research Company | ÆäÀÌÁö Á¤º¸: ¿µ¹® 175 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

3D ½ÉÀå ¸ÅÇÎ ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ °­·ÂÇÑ ¼ºÀåÀÌ Àü¸ÁµË´Ï´Ù. 2028³â¿¡´Â CAGR 9.7%·Î 25¾ï ´Þ·¯·Î ¼ºÀåÇÕ´Ï´Ù. ¿¹Ãø ±â°£ Áß ¿¹»óµÇ´Â ¼ºÀåÀº ±Þ¼ÓÇÑ µµ½ÃÈ­, Á¶±â ¹× Á¤È®ÇÑ Áø´Ü¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õÀÇ ÀÎ½Ä Áõ°¡, ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °ü½É Áõ°¡, ½Ç½Ã°£ ¹× °íÇØ»óµµ ½ÉÀå ¸ÅÇο¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ÀÇÇØ ÁÖµµµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ÀΰøÁö´É°ú ¸Ó½Å·¯´×ÀÇ ÅëÇÕ, ȯÀÚ Áß½É Ä¡·á¿¡ ´ëÇÑ ÁýÁß, º¹ÀâÇÑ ºÎÁ¤¸Æ °ü¸®¿¡ ´ëÇÑ Àû¿ë È®´ë, ½Ç½Ã°£ 3D ½Ã°¢È­ ¹× ¸ÅÇÎÀÇ ¹ßÀü, Àü±Ø ¹Ðµµ°¡ ³ô¾ÆÁø Ä«Å×ÅÍ ¼³°è °³¼± µîÀÌ ÀÖ½À´Ï´Ù.

½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡´Â 3D ½ÉÀå ¸ÅÇÎ ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½ÉÇ÷°ü Áúȯ Áõ°¡´Â °í·ÉÈ­, °Ç°­¿¡ ÇØ·Î¿î »ýÈ° ½À°ü, ºñ¸¸, ´ç´¢º´, °íÇ÷¾Ð, ½ºÆ®·¹½º, ½ºÆ®·¹½º, À¯Àü, ȯ°æ ¿À¿°, Á¦ÇÑµÈ ÀÇ·á Á¢±Ù¼º, »çȸ °æÁ¦Àû °ÝÂ÷ µîÀÇ ¿äÀο¡ ÀÇÇØ ¿µÇâÀ»¹ÞÀ¸¸ç, 3D ½ÉÀå ¸ÅÇÎ ½Ã½ºÅÛÀº ½ÉÀå È°µ¿ÀÇ »ó¼¼ÇÑ ½Ç½Ã°£Áöµµ¸¦ Á¦°øÇÏ¿© ºÎÁ¤¸Æ ¹× ±âŸ ½ÉÀå °ü·Ã ¹®Á¦ÀÇ Á¤È®ÇÑ Áø´Ü ¹× Ä¡·á¸¦ Áö¿øÇÕ´Ï´Ù. ºÎÁ¤¸Æ ¹× ±âŸ ½ÉÀå °ü·Ã ¹®Á¦ÀÇ Á¤È®ÇÑ Áø´Ü°ú Ä¡·á¸¦ Áö¿øÇÏ¿© ½ÉÇ÷°ü Áúȯ ȯÀÚ¸¦ µ½½À´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 1¿ù ¿µ±¹¿¡ ±â¹ÝÀ» µÐ ½ÉÇ÷°ü ¿¬±¸ ÀÚ¼±´ÜüÀÎ ¿µ±¹ ½ÉÀåÀç´Ü(British Heart Foundation)Àº ³²¼º 400¸¸ ¸í, ¿©¼º 360¸¸ ¸íÀ» Æ÷ÇÔÇØ ¿µ±¹³» ¾à 760¸¸ ¸íÀÌ ½ÉÀå ¹× ¼øȯ±â ÁúȯÀ» ¾Î°í ÀÖ´Ù°í º¸°íÇß½À´Ï´Ù. ÀÌ·¯ÇÑ Áúº´Àº ¿µ±¹ Àüü »ç¸ÁÀÇ ¾à 27%¸¦ Â÷ÁöÇϸç, ¿¬°£ 17¸¸ ¸í ÀÌ»ó, ¸ÅÀÏ ¾à 480¸íÀÌ »ç¸ÁÇÏ°í ÀÖ½À´Ï´Ù. °á°úÀûÀ¸·Î ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡´Â 3D ½ÉÀå ¸ÅÇÎ ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡ÇÏ°í ÀÖ½À´Ï´Ù.

3D ½ÉÀå ¸ÅÇÎ ½Ã½ºÅÛ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº Áø´Ü Á¤È®µµ¸¦ ³ôÀÌ°í Ä¡·á °á°ú¸¦ °³¼±Çϱâ À§ÇØ ¸Ó½Å·¯´× ±â´ÉÀ» °®Ãá ½Ã½ºÅÛ µî ÷´Ü ¼Ö·ç¼Ç °³¹ß¿¡ ÁÖ·ÂÇÏ°í ÀÖ½À´Ï´Ù. ¸Ó½Å·¯´× ±â´ÉÀ» °®Ãá 3D ½ÉÀå ¸ÅÇÎ ½Ã½ºÅÛÀº ½ÉÀåÀÇ Àü±âÀû È°µ¿ÀÇ 3Â÷¿ø ¸ÅÇΰú ÀΰøÁö´É ¾Ë°í¸®ÁòÀ» ÅëÇÕÇÑ °ÍÀÔ´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 5¿ù ¹Ì±¹ÀÇ ½ÉÀå ºÎÁ¤¸Æ Ä¡·á ¼Ö·ç¼Ç Àü¹® ±â¾÷ ¹ÙÀÌ¿À¼¾½º À¥½ºÅÍ(Biosense Webster)´Â CARTO 3 ½Ã½ºÅÛ ¹öÀü 8À» Ãâ½ÃÇß½À´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº CARTO ELEVATE ¸ðµâ ¹× CARTOSOUND FAM ¸ðµâ°ú °°Àº ¸ðµâÀ» ÅëÇÑ ¸Ó½Å·¯´×À» ÅëÇØ Àü±â »ý¸®ÇÐÀÚ°¡ ¼öÇàÇÏ´Â Ä«Å×ÅÍ ÀýÁ¦¼úÀÇ È¿À²¼º, ÀÏ°ü¼º ¹× Á¤È®¼ºÀ» Çâ»ó½ÃÅ°±â À§ÇØ ¼³°èµÈ CARTO 3 ½Ã½ºÅÛÀº ½ÅÈ£ ºÐ¼®À» °­È­ÇÏ°íÀ» °­È­ÇÏ°í, ±âÁú Ư¼ºÈ­¸¦ °³¼±Çϸç, º¸´Ù È¿°úÀûÀÎ ½Ã¼ú °æÇèÀ» À§ÇØ ÃÊÀ½ÆÄ ±â¼úÀ» ÅëÇÕÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ½ÃÀåÀÇ Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

  • °íÀÎÇ÷¹À̼ÇÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ
  • ¿ìÅ©¶óÀ̳ª¡¤·¯½Ã¾Æ ÀüÀïÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ
  • ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ

Á¦5Àå ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¼ºÀå

  • ¼¼°èÀÇ 3D ½ÉÀå ¸ÅÇÎ ½Ã½ºÅÛ ½ÃÀå : ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ¼¼°èÀÇ 3D ½ÉÀå ¸ÅÇÎ ½Ã½ºÅÛ ½ÃÀå ½ÇÀû : ±Ô¸ð¿Í ¼ºÀå, 2018-2023
  • ¼¼°èÀÇ 3D ½ÉÀå ¸ÅÇÎ ½Ã½ºÅÛ ½ÃÀå ¿¹Ãø : ±Ô¸ð¿Í ¼ºÀå, 2023-2028, 2033F

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

  • ¼¼°èÀÇ 3D ½ÉÀå ¸ÅÇÎ ½Ã½ºÅÛ ½ÃÀå : Á¦Ç°º°, ½ÇÀû°ú ¿¹Ãø, 2018-2023, 2023-2028F, 2033F
  • ÁöµµÁ¦ÀÛ ½Ã½ºÅÛ
  • Ä«Å×ÅÍ ÁöµµÁ¦ÀÛ
  • ÁöµµÁ¦ÀÛ ¾×¼¼¼­¸®
  • ÁöµµÁ¦ÀÛ ¼ÒÇÁÆ®¿þ¾î
  • ±âŸ Á¦Ç°
  • ¼¼°èÀÇ 3D ½ÉÀå ¸ÅÇÎ ½Ã½ºÅÛ ½ÃÀå : ±â¼úº°, ½ÇÀû°ú ¿¹Ãø, 2018-2023, 2023-2028F, 2033F
  • Àü±â ÇغÎÇÐÀû ÁöµµÁ¦ÀÛ
  • ÀÚ±â°ø¸í¿µ»ó(MRI) ÁöµµÁ¦ÀÛ
  • ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(CT) ÁöµµÁ¦ÀÛ
  • ÃÊÀ½ÆÄ ÁöµµÁ¦ÀÛ
  • ±âŸ ±â¼ú
  • ¼¼°èÀÇ 3D ½ÉÀå ¸ÅÇÎ ½Ã½ºÅÛ ½ÃÀå : ¿ëµµº°, ½ÇÀû°ú ¿¹Ãø, 2018-2023, 2023-2028F, 2033F
  • ½É¹æ¼¼µ¿
  • ½É½Çºó¹Ú
  • ½É¹æÁ¶µ¿
  • »ó½Ç¼ººó¹Ú
  • ±âŸ ¿ëµµ
  • ¼¼°èÀÇ 3D ½ÉÀå ¸ÅÇÎ ½Ã½ºÅÛ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, ½ÇÀû°ú ¿¹Ãø, 2018-2023, 2023-2028F, 2033F
  • º´¿ø
  • ½ÉÀå Ä«Å×ÅÍ °Ë»ç½Ç
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • Çмú¿¬±¸±â°ü
  • ±âŸ ÃÖÁ¾»ç¿ëÀÚ

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

  • ¼¼°èÀÇ 3D ½ÉÀå ¸ÅÇÎ ½Ã½ºÅÛ ½ÃÀå : Áö¿ªº°, ½ÇÀû°ú ¿¹Ãø, 2018-2023, 2023-2028F, 2033F
  • ¼¼°èÀÇ 3D ½ÉÀå ¸ÅÇÎ ½Ã½ºÅÛ ½ÃÀå : ±¹°¡º°, ½ÇÀû°ú ¿¹Ãø, 2018-2023, 2023-2028F, 2033F

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

  • 3D ½ÉÀå ¸ÅÇÎ ½Ã½ºÅÛ ½ÃÀå : °æÀï ±¸µµ
  • 3D ½ÉÀå ¸ÅÇÎ ½Ã½ºÅÛ ½ÃÀå : ±â¾÷ °³¿ä
    • Hitachi Ltd.
    • Abbott Laboratories
    • Siemens Healthineers
    • Koninklijke Philips N.V
    • GE HealthCare Technologies Inc

Á¦31Àå ±âŸ ´ë±â¾÷°ú Çõ½ÅÀû ±â¾÷

  • Boston Scientific Corporation
  • Medtronic PLC
  • Biotronik Inc
  • Microport Scientific Inc.
  • Biosense Webster Inc.
  • BioSig Technologies Inc.
  • Heartflow Inc.
  • Stereotaxis Inc.
  • Kardium Inc.
  • Acutus Medical Inc.
  • Volta Medical Inc.
  • Catheter Precision Inc.
  • Osypka Medical Inc.
  • Sichuan Jinjiang Electronic Science and Technology Co Ltd
  • APN Health LLC

Á¦32Àå °æÀï º¥Ä¡¸¶Å·

Á¦33Àå °æÀï ´ë½Ãº¸µå

Á¦34Àå ÁÖ¿ä ÇÕº´°ú Àμö

Á¦35Àå ÇâÈÄ Àü¸Á°ú ÀáÀçÀû ºÐ¼®

Á¦36Àå ºÎ·Ï

KSA 24.09.30

A three-dimensional (3D) cardiac mapping system is a medical device that uses specialized catheters with electrodes inserted into the heart chambers. This system is employed in electrophysiology procedures to generate detailed, three-dimensional maps of the heart's electrical activity.

Key components of 3D cardiac mapping systems include mapping systems, mapping catheters, mapping accessories, and mapping software. Mapping systems create precise spatial representations of cardiac anatomy and electrical activity to aid in the diagnosis and treatment of cardiac arrhythmias. These systems utilize technologies such as electroanatomical mapping, magnetic resonance imaging (MRI) mapping, computed tomography (CT) mapping, and ultrasound mapping. They are used to address conditions such as atrial fibrillation, ventricular tachycardia, atrial flutter, and supraventricular tachycardia. The systems are employed in various settings, including hospitals, cardiac catheterization laboratories, ambulatory surgical centers, and academic and research institutes.

The 3D cardiac mapping system market research report is one of a series of new reports from The Business Research Company that provides 3D cardiac mapping system market statistics, including 3D cardiac mapping system industry global market size, regional shares, competitors with a 3D cardiac mapping system market share, detailed 3D cardiac mapping system market segments, market trends and opportunities, and any further data you may need to thrive in the 3D cardiac mapping system industry. This 3D cardiac mapping system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The 3D cardiac mapping system market size has grown strongly in recent years. It will grow from $1.57 billion in 2023 to $1.73 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The growth during the historic period can be attributed to the high prevalence of atrial fibrillation, increasing rates of obesity, the widespread adoption of sedentary lifestyles, favorable economic conditions, and rising disposable incomes.

The 3D cardiac mapping system market size is expected to see strong growth in the next few years. It will grow to $2.50 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%. The anticipated growth during the forecast period is expected to be driven by rapid urbanization, increasing demand for early and accurate diagnosis, heightened awareness among healthcare providers, a growing emphasis on personalized medicine, and the rising need for real-time, high-resolution cardiac mapping. Key trends for this period include the integration of artificial intelligence and machine learning, a focus on patient-centric care, expanded applications in managing complex arrhythmias, advancements in real-time 3D visualization and mapping, and improved catheter designs with higher electrode density.

The increasing prevalence of cardiovascular diseases is anticipated to drive the growth of the 3D cardiac mapping system market. The rise in cardiovascular diseases is influenced by factors such as aging, unhealthy lifestyles, obesity, diabetes, high blood pressure, stress, genetics, environmental pollution, limited access to healthcare, and socioeconomic disparities. A 3D Cardiac Mapping System aids patients with cardiovascular conditions by providing detailed, real-time maps of heart activity, which supports precise diagnosis and treatment of arrhythmias and other heart-related issues. For example, in January 2024, the British Heart Foundation, a UK-based cardiovascular research charity, reported that approximately 7.6 million people in the UK are affected by heart and circulatory diseases, including 4 million men and 3.6 million women. These diseases account for around 27% of all deaths in the UK, leading to over 170,000 deaths annually, or about 480 deaths each day. Consequently, the increasing prevalence of cardiovascular diseases is fueling the growth of the 3D cardiac mapping system market.

Leading companies in the 3D cardiac mapping system market are concentrating on developing advanced solutions, such as systems equipped with machine learning capabilities, to enhance diagnostic accuracy and improve treatment outcomes. 3D cardiac mapping systems with machine learning integrate three-dimensional mapping of the heart's electrical activity with artificial intelligence algorithms. For instance, in May 2024, Biosense Webster Inc., a US-based company specializing in cardiac arrhythmia treatment solutions, launched the CARTO 3 System Version 8. This system features machine learning through modules such as the CARTO ELEVATE Module and the CARTOSOUND FAM Module, designed to boost efficiency, consistency, and precision during catheter ablation procedures performed by electrophysiologists. The CARTO 3 system enhances signal analysis, refines substrate characterization, and integrates ultrasound technology for a more effective procedure experience.

In August 2022, Medtronic plc, an Ireland-based medical equipment manufacturer, acquired Affera Inc. for $0.925 billion. This acquisition enables Medtronic to provide a fully integrated diagnostic and therapeutic system for treating various cardiac arrhythmias, including atrial fibrillation. Affera Inc., a US-based medical technology company, offers the Affera Prism-1 cardiac mapping and navigation platform.

Major companies operating in the 3D cardiac mapping system market are Hitachi Ltd., Abbott Laboratories, Siemens Healthineers, Koninklijke Philips N.V, GE HealthCare Technologies Inc, Boston Scientific Corporation, Medtronic PLC, Biotronik Inc, Microport Scientific Inc., Biosense Webster Inc., BioSig Technologies Inc., Heartflow Inc., Stereotaxis Inc., Kardium Inc., Acutus Medical Inc., Volta Medical Inc., Catheter Precision Inc., Osypka Medical Inc., Sichuan Jinjiang Electronic Science and Technology Co Ltd, APN Health LLC, CoreMap Inc.

North America was the largest region in the 3D cardiac mapping system market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the 3D cardiac mapping system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the 3D cardiac mapping system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The 3D cardiac mapping system market consists of revenues earned by entities by providing services such as arrhythmia detection, ablation guidance, cardiac anatomy visualization, integration with imaging modalities, real-time monitoring, preoperative planning, and postoperative assessment. The market value includes the value of related goods sold by the service provider or included within the service offering. The 3D cardiac mapping system market also includes sales of cardiac ablation devices, electrophysiology recording systems, fluoroscopy imaging systems, real-time navigation systems, radiofrequency generators, and cryoablation catheters. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

3D Cardiac Mapping System Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on 3D cardiac mapping system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for 3D cardiac mapping system ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The 3D cardiac mapping system market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Mapping Systems; Mapping Catheters; Mapping Accessories; Mapping Software; Other Products
  • 2) By Technology: Electroanatomical Mapping; Magnetic Resonance Imaging (MRI) Mapping; Computed Tomography (CT) Mapping; Ultrasound Mapping; Other Technologies
  • 3) By Application: Atrial Fibrillation; Ventricular Tachycardia; Atrial Flutter; Supraventricular Tachycardia; Other Applications
  • 4) By End Users: Hospitals; Cardiac Catheterization Laboratories; Ambulatory Surgical Centers; Academic And Research Institutes; Other End Users
  • Companies Mentioned: Hitachi Ltd.; Abbott Laboratories; Siemens Healthineers; Koninklijke Philips N.V; GE HealthCare Technologies Inc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. 3D Cardiac Mapping System Market Characteristics

3. 3D Cardiac Mapping System Market Trends And Strategies

4. 3D Cardiac Mapping System Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global 3D Cardiac Mapping System Market Size and Growth

  • 5.1. Global 3D Cardiac Mapping System Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global 3D Cardiac Mapping System Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global 3D Cardiac Mapping System Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. 3D Cardiac Mapping System Market Segmentation

  • 6.1. Global 3D Cardiac Mapping System Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Mapping Systems
  • Mapping Catheters
  • Mapping Accessories
  • Mapping Software
  • Other Products
  • 6.2. Global 3D Cardiac Mapping System Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Electroanatomical Mapping
  • Magnetic Resonance Imaging (MRI) Mapping
  • Computed Tomography (CT) Mapping
  • Ultrasound Mapping
  • Other Technologies
  • 6.3. Global 3D Cardiac Mapping System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Atrial Fibrillation
  • Ventricular Tachycardia
  • Atrial Flutter
  • Supraventricular Tachycardia
  • Other Applications
  • 6.4. Global 3D Cardiac Mapping System Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Cardiac Catheterization Laboratories
  • Ambulatory Surgical Centers
  • Academic And Research Institutes
  • Other End Users

7. 3D Cardiac Mapping System Market Regional And Country Analysis

  • 7.1. Global 3D Cardiac Mapping System Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global 3D Cardiac Mapping System Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific 3D Cardiac Mapping System Market

  • 8.1. Asia-Pacific 3D Cardiac Mapping System Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific 3D Cardiac Mapping System Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific 3D Cardiac Mapping System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific 3D Cardiac Mapping System Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China 3D Cardiac Mapping System Market

  • 9.1. China 3D Cardiac Mapping System Market Overview
  • 9.2. China 3D Cardiac Mapping System Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China 3D Cardiac Mapping System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China 3D Cardiac Mapping System Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India 3D Cardiac Mapping System Market

  • 10.1. India 3D Cardiac Mapping System Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India 3D Cardiac Mapping System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India 3D Cardiac Mapping System Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan 3D Cardiac Mapping System Market

  • 11.1. Japan 3D Cardiac Mapping System Market Overview
  • 11.2. Japan 3D Cardiac Mapping System Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan 3D Cardiac Mapping System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan 3D Cardiac Mapping System Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia 3D Cardiac Mapping System Market

  • 12.1. Australia 3D Cardiac Mapping System Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia 3D Cardiac Mapping System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia 3D Cardiac Mapping System Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia 3D Cardiac Mapping System Market

  • 13.1. Indonesia 3D Cardiac Mapping System Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia 3D Cardiac Mapping System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia 3D Cardiac Mapping System Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea 3D Cardiac Mapping System Market

  • 14.1. South Korea 3D Cardiac Mapping System Market Overview
  • 14.2. South Korea 3D Cardiac Mapping System Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea 3D Cardiac Mapping System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea 3D Cardiac Mapping System Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe 3D Cardiac Mapping System Market

  • 15.1. Western Europe 3D Cardiac Mapping System Market Overview
  • 15.2. Western Europe 3D Cardiac Mapping System Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe 3D Cardiac Mapping System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe 3D Cardiac Mapping System Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK 3D Cardiac Mapping System Market

  • 16.1. UK 3D Cardiac Mapping System Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK 3D Cardiac Mapping System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK 3D Cardiac Mapping System Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany 3D Cardiac Mapping System Market

  • 17.1. Germany 3D Cardiac Mapping System Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany 3D Cardiac Mapping System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany 3D Cardiac Mapping System Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France 3D Cardiac Mapping System Market

  • 18.1. France 3D Cardiac Mapping System Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France 3D Cardiac Mapping System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France 3D Cardiac Mapping System Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy 3D Cardiac Mapping System Market

  • 19.1. Italy 3D Cardiac Mapping System Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy 3D Cardiac Mapping System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy 3D Cardiac Mapping System Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain 3D Cardiac Mapping System Market

  • 20.1. Spain 3D Cardiac Mapping System Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain 3D Cardiac Mapping System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain 3D Cardiac Mapping System Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe 3D Cardiac Mapping System Market

  • 21.1. Eastern Europe 3D Cardiac Mapping System Market Overview
  • 21.2. Eastern Europe 3D Cardiac Mapping System Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe 3D Cardiac Mapping System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe 3D Cardiac Mapping System Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia 3D Cardiac Mapping System Market

  • 22.1. Russia 3D Cardiac Mapping System Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia 3D Cardiac Mapping System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia 3D Cardiac Mapping System Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America 3D Cardiac Mapping System Market

  • 23.1. North America 3D Cardiac Mapping System Market Overview
  • 23.2. North America 3D Cardiac Mapping System Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America 3D Cardiac Mapping System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America 3D Cardiac Mapping System Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA 3D Cardiac Mapping System Market

  • 24.1. USA 3D Cardiac Mapping System Market Overview
  • 24.2. USA 3D Cardiac Mapping System Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA 3D Cardiac Mapping System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA 3D Cardiac Mapping System Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada 3D Cardiac Mapping System Market

  • 25.1. Canada 3D Cardiac Mapping System Market Overview
  • 25.2. Canada 3D Cardiac Mapping System Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada 3D Cardiac Mapping System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada 3D Cardiac Mapping System Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America 3D Cardiac Mapping System Market

  • 26.1. South America 3D Cardiac Mapping System Market Overview
  • 26.2. South America 3D Cardiac Mapping System Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America 3D Cardiac Mapping System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America 3D Cardiac Mapping System Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil 3D Cardiac Mapping System Market

  • 27.1. Brazil 3D Cardiac Mapping System Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil 3D Cardiac Mapping System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil 3D Cardiac Mapping System Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East 3D Cardiac Mapping System Market

  • 28.1. Middle East 3D Cardiac Mapping System Market Overview
  • 28.2. Middle East 3D Cardiac Mapping System Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East 3D Cardiac Mapping System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East 3D Cardiac Mapping System Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa 3D Cardiac Mapping System Market

  • 29.1. Africa 3D Cardiac Mapping System Market Overview
  • 29.2. Africa 3D Cardiac Mapping System Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa 3D Cardiac Mapping System Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa 3D Cardiac Mapping System Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. 3D Cardiac Mapping System Market Competitive Landscape And Company Profiles

  • 30.1. 3D Cardiac Mapping System Market Competitive Landscape
  • 30.2. 3D Cardiac Mapping System Market Company Profiles
    • 30.2.1. Hitachi Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Abbott Laboratories
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Siemens Healthineers
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Koninklijke Philips N.V
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. GE HealthCare Technologies Inc
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. 3D Cardiac Mapping System Market Other Major And Innovative Companies

  • 31.1. Boston Scientific Corporation
  • 31.2. Medtronic PLC
  • 31.3. Biotronik Inc
  • 31.4. Microport Scientific Inc.
  • 31.5. Biosense Webster Inc.
  • 31.6. BioSig Technologies Inc.
  • 31.7. Heartflow Inc.
  • 31.8. Stereotaxis Inc.
  • 31.9. Kardium Inc.
  • 31.10. Acutus Medical Inc.
  • 31.11. Volta Medical Inc.
  • 31.12. Catheter Precision Inc.
  • 31.13. Osypka Medical Inc.
  • 31.14. Sichuan Jinjiang Electronic Science and Technology Co Ltd
  • 31.15. APN Health LLC

32. Global 3D Cardiac Mapping System Market Competitive Benchmarking

33. Global 3D Cardiac Mapping System Market Competitive Dashboard

34. Key Mergers And Acquisitions In The 3D Cardiac Mapping System Market

35. 3D Cardiac Mapping System Market Future Outlook and Potential Analysis

  • 35.1 3D Cardiac Mapping System Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 3D Cardiac Mapping System Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 3D Cardiac Mapping System Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦